Today, health-care analyst Brenton Flynn looks at the scary reports that hackers may have the ability to remotely "hack" into life-saving medical devices such as pacemakers and insulin pumps and change their settings to deadly levels.

While reports like this make for great sensational headlines, they should be far removed from the investor's psyche. Brenton doesn't think these reports materially affect any company's investment thesis. Instead, in the following video he discusses the true risks for medical-device companies and offers up one company that's designing significantly safer devices.

When it comes to do-or-die businesses, the biotech industry takes the cake. Arena Pharmaceuticals is one recent success story in the industry after gaining FDA approval for its innovative obesity drug. While the future looks bright for Arena, there are still plenty of obstacles ahead. In our brand-new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.

Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool owns shares of St. Jude Medical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.